https://www.shine.cn/news/metro/2010208044/
"Party Secretary Li holds video conference with BioNTech CEO
Shanghai Party Secretary Li Qiang yesterday held a video conference with Ugur Sahin, chief executive officer and co-founder of Germany pharmaceutical firm BioNTech, on cooperation in developing vaccines against the novel coronavirus.
We hope BioNTech and Fosun Pharma Industrial will strengthen cooperation in developing safe and reliable vaccines against the coronavirus and innovative therapies, and carry out comprehensive cooperation in research and development, and production of biomedicines in Shanghai, Li said.
He added that Shanghai will continue to deepen reform and opening up under the leadership of President Xi Jinping, push forward the development of the economy and society against the COVID-19 pandemic, and continue to create a first class business environment to provide excellent service for enterprises from home and abroad to develop in Shanghai."
Im wesentlichen altbekanntes chinesisches BlaBla. Scheint mir, als sei Fosun mit den Versuchen, für BNT162b2 den vor chinesischer Zulassung erforderlichen "bridging trial" genehmigt zu bekommen, auf Grund gelaufen, und hat nun internationale Hilfe in personam U. Sahin mobilisiert. Mal sehen, was das bringt.. Mangelnden Einsatz zumindest kann man U. Sahin nicht vorwerfen. Ich frage mich, wie er bei den ganzen Interviews und Video-Konferenzen noch Zeit findet, sein Geschäft zu führen. |